199 related articles for article (PubMed ID: 1849139)
1. Membrane-anchored form of v-sis/PDGF-B induces mitogenesis without detectable PDGF receptor autophosphorylation.
Lee BA; Donoghue DJ
J Cell Biol; 1991 Apr; 113(2):361-70. PubMed ID: 1849139
[TBL] [Abstract][Full Text] [Related]
2. Autocrine stimulation by the v-sis gene product requires a ligand-receptor interaction at the cell surface.
Hannink M; Donoghue DJ
J Cell Biol; 1988 Jul; 107(1):287-98. PubMed ID: 2455725
[TBL] [Abstract][Full Text] [Related]
3. The v-sis oncogene product but not platelet-derived growth factor (PDGF) A homodimers activate PDGF alpha and beta receptors intracellularly and initiate cellular transformation.
Bejcek BE; Hoffman RM; Lipps D; Li DY; Mitchell CA; Majerus PW; Deuel TF
J Biol Chem; 1992 Feb; 267(5):3289-93. PubMed ID: 1310684
[TBL] [Abstract][Full Text] [Related]
4. The v-sis oncoprotein loses transforming activity when targeted to the early Golgi complex.
Hart KC; Xu YF; Meyer AN; Lee BA; Donoghue DJ
J Cell Biol; 1994 Dec; 127(6 Pt 2):1843-57. PubMed ID: 7806564
[TBL] [Abstract][Full Text] [Related]
5. Intracellular retention of membrane-anchored v-sis protein abrogates autocrine signal transduction.
Lee BA; Donoghue DJ
J Cell Biol; 1992 Sep; 118(5):1057-70. PubMed ID: 1324943
[TBL] [Abstract][Full Text] [Related]
6. The v-sis protein retains biological activity as a type II membrane protein when anchored by various signal-anchor domains, including the hydrophobic domain of the bovine papilloma virus E5 oncoprotein.
Xu YF; Meyer AN; Webster MK; Lee BA; Donoghue DJ
J Cell Biol; 1993 Nov; 123(3):549-60. PubMed ID: 8227125
[TBL] [Abstract][Full Text] [Related]
7. v-mos suppresses platelet-derived growth factor (PDGF) type-beta receptor autophosphorylation and inhibits PDGF-BB-mediated signal transduction.
Faller DV; Mundschau LJ; Forman LW; Quiñones MA
J Biol Chem; 1994 Feb; 269(7):5022-9. PubMed ID: 8106477
[TBL] [Abstract][Full Text] [Related]
8. Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.
Buchdunger E; Zimmermann J; Mett H; Meyer T; Müller M; Regenass U; Lydon NB
Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2558-62. PubMed ID: 7708684
[TBL] [Abstract][Full Text] [Related]
9. Epigallocathechin-3 gallate selectively inhibits the PDGF-BB-induced intracellular signaling transduction pathway in vascular smooth muscle cells and inhibits transformation of sis-transfected NIH 3T3 fibroblasts and human glioblastoma cells (A172).
Ahn HY; Hadizadeh KR; Seul C; Yun YP; Vetter H; Sachinidis A
Mol Biol Cell; 1999 Apr; 10(4):1093-104. PubMed ID: 10198059
[TBL] [Abstract][Full Text] [Related]
10. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
[TBL] [Abstract][Full Text] [Related]
11. Platelet-derived growth factor (PDGF) B and A homodimers transform murine fibroblasts depending on the genetic background of the cell.
Kim HR; Upadhyay S; Korsmeyer S; Deuel TF
J Biol Chem; 1994 Dec; 269(48):30604-8. PubMed ID: 7982979
[TBL] [Abstract][Full Text] [Related]
12. Platelet-derived growth factor-B/v-sis confers a tumorigenic and metastatic phenotype to human T98G glioblastoma cells.
Potapova O; Fakhrai H; Baird S; Mercola D
Cancer Res; 1996 Jan; 56(2):280-6. PubMed ID: 8542581
[TBL] [Abstract][Full Text] [Related]
13. Cell surface retention sequence binding protein-1 interacts with the v-sis gene product and platelet-derived growth factor beta-type receptor in simian sarcoma virus-transformed cells.
Boensch C; Huang SS; Connolly DT; Huang JS
J Biol Chem; 1999 Apr; 274(15):10582-9. PubMed ID: 10187853
[TBL] [Abstract][Full Text] [Related]
14. Rapid turnover of the platelet-derived growth factor receptor in sis-transformed cells and reversal by suramin. Implications for the mechanism of autocrine transformation.
Huang SS; Huang JS
J Biol Chem; 1988 Sep; 263(25):12608-18. PubMed ID: 2842336
[TBL] [Abstract][Full Text] [Related]
15. Cell surface expression of membrane-anchored v-sis gene products: glycosylation is not required for cell surface transport.
Hannink M; Donoghue DJ
J Cell Biol; 1986 Dec; 103(6 Pt 1):2311-22. PubMed ID: 3536965
[TBL] [Abstract][Full Text] [Related]
16. Alanine mutagenesis of conserved residues in the platelet-derived growth factor family: identification of residues necessary for dimerization and transformation.
Maher DW; Strawn LM; Donoghue DJ
Oncogene; 1993 Mar; 8(3):533-41. PubMed ID: 8437840
[TBL] [Abstract][Full Text] [Related]
17. Imbalanced expression of cellular nuclear oncogenes caused by v-sis/PDGF-2.
Sonobe MH; Bravo R; Armelin MS
Oncogene; 1991 Sep; 6(9):1531-7. PubMed ID: 1923519
[TBL] [Abstract][Full Text] [Related]
18. Blockade of autocrine stimulation in simian sarcoma virus-transformed cells reverses down-regulation of platelet-derived growth factor receptors.
Garrett JS; Coughlin SR; Niman HL; Tremble PM; Giels GM; Williams LT
Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7466-70. PubMed ID: 6095298
[TBL] [Abstract][Full Text] [Related]
19. Identification of amino acids in the transmembrane and juxtamembrane domains of the platelet-derived growth factor receptor required for productive interaction with the bovine papillomavirus E5 protein.
Petti LM; Reddy V; Smith SO; DiMaio D
J Virol; 1997 Oct; 71(10):7318-27. PubMed ID: 9311809
[TBL] [Abstract][Full Text] [Related]
20. Biological function of PDGF-induced PI-3 kinase activity: its role in alpha PDGF receptor-mediated mitogenic signaling.
Yu JC; Gutkind JS; Mahadevan D; Li W; Meyers KA; Pierce JH; Heidaran MA
J Cell Biol; 1994 Oct; 127(2):479-87. PubMed ID: 7929590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
